Cite
HARVARD Citation
Ozelo, M. et al. (n.d.). Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial. Haemophilia. pp. e436-e439. [Online].